ABCG2 and non-small cell lung carcinoma: The correlation of UCP2 downregulation and the increase in Nrf2 and ABCG2 levels with chemotherapy responsiveness was verified by assays using chemo-sensitive and -resistant clinical NSCLC samples (Figure 5G).